Perspectives

Verily in ‘25 and beyond: powering AI for precision health

Precision health blog

Advancing care delivery in a rapidly changing landscape

Grandmother and grand daughter looking at each other alongside close up of scientist in gloves working in a lab.

What population data could do for the individual — early warning signs with proactive monitoring

Precision health blog

Webinars

Verily PlatformData Capabilities

Unlock the value of your biomedical data

Download recording

Verily LightpathMetabolic

The key to unlocking GLP-1 potential

Download recording

Verily Viewpoint Digital Protocols

Accelerate Clinical Trials: Unlocking Efficiency with Digital Protocols

Download recording

Publications

See all

Proceedings of Machine Learning Research

Selective Fine-tuning on LLM-labeled Data May Reduce Reliance on Human Annotation: A Case Study Using Schedule-of-Event Table Detection

International Congress of Parkinson’s Disease and Movement Disorders Parkinson’s DiseaseNeurologyDigital Biomarkers

Developing composite measures that track physical activity change in people with early-stage Parkinson’s disease using machine learning and wearable sensors

International Congress of Parkinson’s Disease and Movement Disorders Parkinson’s DiseaseNeurologyDigital Biomarkers

Proposed framework to evaluate the ability of digital measures to track early stage Parkinson’s disease progression

Tech blog

See all

Why Verily uses FHIRPath

N of 1 series

Watch series

New

Episode 4 - A Brighter Way to Care

Episode 3 - A New View on Research

Episode 2 - Eye on the Future

Episode 1 - A Watershed Moment

1 / 2

Press releases

See all

Verily Continues Partnership with Vanderbilt University Medical Center to Support Next Generation of NIH All of Us Researcher Workbench

Verily awarded research grant from The Michael J. Fox Foundation to generate one of the world’s largest, high-dimensional molecular datasets of Parkinson’s patients

Verily welcomes new organizations who will use Workbench to manage large biomedical datasets and accelerate research

Verily-led data and technology consortium receives $4.8M award from NIH for platform to power systems biology research across Accelerating Medicines Partnership® programs

Perspectives

Verily in ‘25 and beyond: powering AI for precision health

Advancing care delivery in a rapidly changing landscape

What population data could do for the individual — early warning signs with proactive monitoring

Webinars

Unlock the value of your biomedical data

The key to unlocking GLP-1 potential

Accelerate Clinical Trials: Unlocking Efficiency with Digital Protocols

Publications

Selective Fine-tuning on LLM-labeled Data May Reduce Reliance on Human Annotation: A Case Study Using Schedule-of-Event Table Detection

Developing composite measures that track physical activity change in people with early-stage Parkinson’s disease using machine learning and wearable sensors

Proposed framework to evaluate the ability of digital measures to track early stage Parkinson’s disease progression

Tech blog

Why Verily uses FHIRPath

N of 1 series

Episode 4 - A Brighter Way to Care

Episode 3 - A New View on Research

Episode 2 - Eye on the Future

Episode 1 - A Watershed Moment

Press releases

Verily Continues Partnership with Vanderbilt University Medical Center to Support Next Generation of NIH All of Us Researcher Workbench

Verily awarded research grant from The Michael J. Fox Foundation to generate one of the world’s largest, high-dimensional molecular datasets of Parkinson’s patients

Verily welcomes new organizations who will use Workbench to manage large biomedical datasets and accelerate research

Verily-led data and technology consortium receives $4.8M award from NIH for platform to power systems biology research across Accelerating Medicines Partnership® programs

More about Verily